A cell-based assay was integrated with bioinformatic analysis, and among the predicted targets, ERK1/2 and MEK1 were identified as molecular targets of 22-(4′py)-JA in mediating NSCLC apoptosis. The gene discussed is MAPK3; the disease is non-small cell lung carcinoma.